2.060 Å
X-ray
2005-05-24
Name: | Gag-Pol polyprotein |
---|---|
ID: | POL_HV1B1 |
AC: | P03366 |
Organism: | Human immunodeficiency virus type 1 group M subtype B |
Reign: | Viruses |
TaxID: | 11678 |
EC Number: | 3.4.23.16 |
Chain Name: | Percentage of Residues within binding site |
---|---|
A | 55 % |
B | 45 % |
B-Factor: | 23.519 |
---|---|
Number of residues: | 44 |
Including | |
Standard Amino Acids: | 44 |
Non Standard Amino Acids: | 0 |
Water Molecules: | 0 |
Cofactors: | |
Metals: |
Ligandability | Volume (Å3) |
---|---|
0.702 | 786.375 |
% Hydrophobic | % Polar |
---|---|
39.91 | 60.09 |
According to VolSite |
HET Code: | 0ZT |
---|---|
Formula: | C38H49N5O8 |
Molecular weight: | 703.824 g/mol |
DrugBank ID: | - |
Buried Surface Area: | 61.25 % |
Polar Surface area: | 216.58 Å2 |
Number of | |
---|---|
H-Bond Acceptors: | 8 |
H-Bond Donors: | 6 |
Rings: | 3 |
Aromatic rings: | 3 |
Anionic atoms: | 1 |
Cationic atoms: | 1 |
Rule of Five Violation: | 3 |
Rotatable Bonds: | 21 |
X | Y | Z |
---|---|---|
-7.682 | 15.9054 | 25.8778 |
Represent the protein/ligand binding mode, centered on the ligand
Dashed lines represents hydrogen bonds and metal interactions
Green residue labels for amino acids with hydrophobic contacts (green lines) to the ligand
Ligand | Protein | Interaction | |||
---|---|---|---|---|---|
Atom | Atom | Residue | Distance (Å) | Angle (°) | Type |
CB | CD2 | LEU- 23 | 3.82 | 0 | Hydrophobic |
N1 | OD2 | ASP- 25 | 3.57 | 0 | Ionic (Ligand Cationic) |
N1 | OD1 | ASP- 25 | 3.81 | 0 | Ionic (Ligand Cationic) |
N2 | O | GLY- 27 | 3.15 | 161.8 | H-Bond (Ligand Donor) |
CB2 | CB | ALA- 28 | 3.46 | 0 | Hydrophobic |
O3 | N | ASP- 29 | 3.04 | 160.87 | H-Bond (Protein Donor) |
OE1 | N | ASP- 30 | 2.97 | 158.24 | H-Bond (Protein Donor) |
OE2 | OD2 | ASP- 30 | 2.97 | 161.58 | H-Bond (Protein Donor) |
CG2 | CG2 | VAL- 32 | 3.97 | 0 | Hydrophobic |
CG2 | CD1 | ILE- 47 | 4.28 | 0 | Hydrophobic |
N3 | O | GLY- 48 | 2.73 | 170.72 | H-Bond (Ligand Donor) |
O4 | N | GLY- 48 | 2.83 | 150.2 | H-Bond (Protein Donor) |
C3 | CG2 | ILE- 50 | 3.72 | 0 | Hydrophobic |
C2 | CD1 | ILE- 50 | 3.4 | 0 | Hydrophobic |
CD11 | CG1 | ILE- 50 | 3.27 | 0 | Hydrophobic |
CE2 | CB | PRO- 81 | 4.26 | 0 | Hydrophobic |
CE1 | CG1 | VAL- 82 | 3.79 | 0 | Hydrophobic |
OS | OD1 | ASP- 125 | 3.19 | 137.83 | H-Bond (Ligand Donor) |
OS | OD2 | ASP- 125 | 3.42 | 168.88 | H-Bond (Ligand Donor) |
N1 | OD2 | ASP- 125 | 2.74 | 163.86 | H-Bond (Ligand Donor) |
N1 | OD1 | ASP- 125 | 3.69 | 0 | Ionic (Ligand Cationic) |
N1 | OD2 | ASP- 125 | 2.74 | 0 | Ionic (Ligand Cationic) |
N | O | GLY- 127 | 2.96 | 135.51 | H-Bond (Ligand Donor) |
C2 | CB | ALA- 128 | 3.91 | 0 | Hydrophobic |
C1 | CB | ASP- 130 | 3.95 | 0 | Hydrophobic |
C1 | CG2 | VAL- 132 | 4.04 | 0 | Hydrophobic |
C1 | CD1 | ILE- 147 | 4.48 | 0 | Hydrophobic |
C3 | CD1 | ILE- 147 | 3.76 | 0 | Hydrophobic |
CG2 | CD1 | ILE- 150 | 4.38 | 0 | Hydrophobic |
CE22 | CG | PRO- 181 | 4.37 | 0 | Hydrophobic |
CE11 | CG | PRO- 181 | 3.47 | 0 | Hydrophobic |
CE21 | CG2 | VAL- 182 | 3.36 | 0 | Hydrophobic |
C2 | CD1 | ILE- 184 | 3.7 | 0 | Hydrophobic |
CD11 | CD1 | ILE- 184 | 3.53 | 0 | Hydrophobic |